BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33129747)

  • 1. CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma.
    Lyapichev KA; Sukswai N; Angelova E; Kersh MJ; Pierce S; Konopleva M; Jain N; Jabbour EJ; Jorgensen JL; Wang SA; Medeiros LJ; Khoury JD; Konoplev S
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e317-e320. PubMed ID: 33129747
    [No Abstract]   [Full Text] [Related]  

  • 2. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
    Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
    Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.
    Gaikwad AS; Donohue RE; Elghetany MT; Sheehan AM; Lu XY; Gramatges MM; McClain KL; Mistretta TA; Punia JN; Moore TJ; Goltsova T; Cubbage M; Curry CV
    Int J Clin Exp Pathol; 2014; 7(9):6225-30. PubMed ID: 25337274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts.
    Hassanein NM; Alcancia F; Perkinson KR; Buckley PJ; Lagoo AS
    Am J Clin Pathol; 2009 Oct; 132(4):573-80. PubMed ID: 19762535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CD123 correlates with the hyperdiploid genotype in acute lymphoblastic leukemia.
    Djokic M; Björklund E; Blennow E; Mazur J; Söderhäll S; Porwit A
    Haematologica; 2009 Jul; 94(7):1016-9. PubMed ID: 19454491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of
    Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
    Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
    Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
    Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
    Jain N; Roberts KG; Jabbour E; Patel K; Eterovic AK; Chen K; Zweidler-McKay P; Lu X; Fawcett G; Wang SA; Konoplev S; Harvey RC; Chen IM; Payne-Turner D; Valentine M; Thomas D; Garcia-Manero G; Ravandi F; Cortes J; Kornblau S; O'Brien S; Pierce S; Jorgensen J; Shaw KR; Willman CL; Mullighan CG; Kantarjian H; Konopleva M
    Blood; 2017 Feb; 129(5):572-581. PubMed ID: 27919910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
    Reshmi SC; Harvey RC; Roberts KG; Stonerock E; Smith A; Jenkins H; Chen IM; Valentine M; Liu Y; Li Y; Shao Y; Easton J; Payne-Turner D; Gu Z; Tran TH; Nguyen JV; Devidas M; Dai Y; Heerema NA; Carroll AJ; Raetz EA; Borowitz MJ; Wood BL; Angiolillo AL; Burke MJ; Salzer WL; Zweidler-McKay PA; Rabin KR; Carroll WL; Zhang J; Loh ML; Mullighan CG; Willman CL; Gastier-Foster JM; Hunger SP
    Blood; 2017 Jun; 129(25):3352-3361. PubMed ID: 28408464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.
    Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B
    Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Ph-like ALL be effectively targeted?
    Maese L; Raetz EA
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101096. PubMed ID: 31779971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD123 expression levels in 846 acute leukemia patients based on standardized immunophenotyping.
    Bras AE; de Haas V; van Stigt A; Jongen-Lavrencic M; Beverloo HB; Te Marvelde JG; Zwaan CM; van Dongen JJM; Leusen JHW; van der Velden VHJ
    Cytometry B Clin Cytom; 2019 Mar; 96(2):134-142. PubMed ID: 30450744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD34(+)CD19(+) cells with CD123 overexpression are a novel prognostic marker in Ph chromosome-positive acute lymphoblastic leukemia].
    Kong Y; Huang XJ; Hao L; Qin YZ; Jiang Q; Jiang H; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):6-10. PubMed ID: 24598641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
    Qin YZ; Jiang Q; Xu LP; Jiang H; Wang Y; Zhao XS; Li ZR; Lai YY; Liu YR; Zhang XH; Liu KY; Huang XJ
    Ann Hematol; 2019 Nov; 98(11):2551-2559. PubMed ID: 31493003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
    Jain P; Gu J; Kanagal-Shamanna R; Tang Z; Patel KP; Yao H; Fang L; Bao HY; Liu CH; Lin P; Medeiros LJ; Lu X
    Leuk Res; 2019 Sep; 84():106176. PubMed ID: 31279181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia.
    Shiraz P; Payne KJ; Muffly L
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32235787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
    Herold T; Schneider S; Metzeler KH; Neumann M; Hartmann L; Roberts KG; Konstandin NP; Greif PA; Bräundl K; Ksienzyk B; Huk N; Schneider I; Zellmeier E; Jurinovic V; Mansmann U; Hiddemann W; Mullighan CG; Bohlander SK; Spiekermann K; Hoelzer D; Brüggemann M; Baldus CD; Dreyling M; Gökbuget N
    Haematologica; 2017 Jan; 102(1):130-138. PubMed ID: 27561722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRLF2-Positive B-Cell Acute Lymphoblastic Leukemia in Adult Patients: A Single-Institution Experience.
    Konoplev S; Lu X; Konopleva M; Jain N; Ouyang J; Goswami M; Roberts KG; Valentine M; Mullighan CG; Bueso-Ramos C; Zweidler-McKay PA; Jorgensen JL; Wang SA
    Am J Clin Pathol; 2017 Apr; 147(4):357-363. PubMed ID: 28340183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
    Roberts KG; Li Y; Payne-Turner D; Harvey RC; Yang YL; Pei D; McCastlain K; Ding L; Lu C; Song G; Ma J; Becksfort J; Rusch M; Chen SC; Easton J; Cheng J; Boggs K; Santiago-Morales N; Iacobucci I; Fulton RS; Wen J; Valentine M; Cheng C; Paugh SW; Devidas M; Chen IM; Reshmi S; Smith A; Hedlund E; Gupta P; Nagahawatte P; Wu G; Chen X; Yergeau D; Vadodaria B; Mulder H; Winick NJ; Larsen EC; Carroll WL; Heerema NA; Carroll AJ; Grayson G; Tasian SK; Moore AS; Keller F; Frei-Jones M; Whitlock JA; Raetz EA; White DL; Hughes TP; Guidry Auvil JM; Smith MA; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Gastier-Foster JM; Mardis E; Wilson RK; Loh ML; Downing JR; Hunger SP; Willman CL; Zhang J; Mullighan CG
    N Engl J Med; 2014 Sep; 371(11):1005-15. PubMed ID: 25207766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable prognosis in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia patients following hematopoietic stem cell transplantation.
    Numata A; Fujisawa S; Itabashi M; Ishii Y; Yamamoto W; Motohashi K; Matsumoto K; Hagihara M; Nakajima H
    Clin Transplant; 2016 May; 30(5):485-6. PubMed ID: 26990549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.